AMGEN INC (AMGN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for AMGN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| AMGN | Director | 70 | ["former executive chairman and chairman of the board of Medtronic plc","chief executive officer of Medtronic","President and Chief Executive Officer of GE Healthcare Systems","experience as chairman of the board of Intel Corporation","senior advisor to Blackstone Life Sciences","inducted into the American Institute for Medical and Biological Engineering College of Fellows","fellow of King’s College London","inducted into the Bakken Society","elected to the National Academy of Engineering"] | ["Compensation and Management Development","M","Audit","Nominating and Corporate Governance Committee","Audit Committee"] | 2026 |
Biography sourced from the proxy statement filing.
S. Omar Ishrak has served as our director since 2021. Dr. Ishrak is the former executive chairman and chairman of the board of Medtronic plc, or Medtronic, a global medical technology company. Dr. Ishrak served as the chairman and Chief Executive Officer of Medtronic from 2011 to 2020 and was executive chairman until 2020. Prior to joining Medtronic, he served as President and Chief Executive Officer of GE Healthcare Systems from 2009 to 2011. Dr. Ishrak was President and Chief Executive Officer of GE Healthcare Clinical Systems from 2005 to 2008 and President and Chief Executive Officer of GE Healthcare Ultrasound and BMD from 1995 to 2004. Dr. Ishrak is the chairman and lead independent director, as well as a member of the Audit Committee and Nominating and Corporate Governance Committee, of Allurion Technologies, Inc., a weight loss platform, having served in these roles since the company s merger in 2023 with Compute Health Acquisition Corporation, a special purpose acquisition company, for which Dr. Ishrak served as chairman of the board of directors from 2021 until the 2023 merger. Dr. Ishrak was a director of Intel Corporation, a multinational corporation and technology company, from 2017 to May 2025, for which he served as chairman of the board from 2020 to 2023. Dr. Ishrak is a member of the board of trustees of the Asia Society, an educational organization dedicated to promoting mutual understanding and strong partnerships between Asia and the U.S. Since 2021, Dr. Ishrak has been a senior advisor to Blackstone Life Sciences, a segment of Blackstone Inc. that invests in the biopharmaceutical and medical technology industries. Dr. Ishrak was inducted into the American Institute for Medical and Biological Engineering College of Fellows in 2016, elected as a fellow of King s College London in 2017, inducted into the Bakken Society in 2020, and elected to the National Academy of Engineering in 2020. Dr. Ishrak received his undergraduate degree and doctorate from the University of London, King s College. Qualifications Our Board concluded that Dr. Ishrak should serve on our Board based on Dr. Ishrak s board and senior executive-level expertise, including his experience as chief executive officer of a global, highly regulated public company in the healthcare industry, his extensive background in medical technologies, manufacturing, international expertise and interest in Asia, and his management and leadership skills.